Evidence map›Paper›PMID 30150471›Full record

ArticleAntimicrobial agents and chemotherapy2018

Diversity of High-Level Aminoglycoside Resistance Mechanisms among Gram-Negative Nosocomial Pathogens in Brazil.

Anelise S Ballaben, Leonardo N Andrade, Renata Galetti, Joseane C Ferreira, Christi L McElheny, Roberta T Mettus, Paulo da Silva, Doroti de Oliveira Garcia, Ana Lucia C Darini, Yohei Doi

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Antimicrobial agents and chemotherapy · 2020
    Article
  5. Genomic Analysis of Carbapenem-ResistantFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anelise S BallabenSchool of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Leonardo N AndradeSchool of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Renata GalettiSchool of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Joseane C FerreiraSchool of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Christi L McElhenyDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Roberta T MettusDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Paulo da SilvaAdolfo Lutz Institute, Ribeirao Preto, Brazil.
Doroti de Oliveira GarciaCenter of Bacteriology, Adolfo Lutz Institute, São Paulo, Brazil.
Ana Lucia C DariniSchool of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Yohei DoiDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA yod4@pitt.edu.

Funding

Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2M
Study Network of Acinetobacter as a Carbapenem-Resistant Pathogen (SNAP)R21AI135522 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2018 to 2019
$460k
Mechanisms and implications of fosfomycin resistance in Escherichia coliR21AI123747 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2016 to 2017
$417k
NIAID NIH HHS R01 AI104895NIAID NIH HHS R21 AI123747NIAID NIH HHS R21 AI135522
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AminoglycosidesAnti-Bacterial AgentsBrazilCross InfectionDrug Resistance, BacterialGram-Negative BacteriaHumansMicrobial Sensitivity TestsRNA, Ribosomal, 16SAminoglycosidesAnti-Bacterial AgentsRNA, Ribosomal, 16S16S ribosomal methyltransferaseAcinetobacter baumanniiaminoglycoside-modifying enzymeKlebsiella pneumoniaePseudomonas aeruginosa

Identifiers

PMID30150471
PMCPMC6201109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.